PT Darya-Varia Laboratoria Tbk is a pharmaceutical company in Indonesia that has been awarded the Top Corporate Award 2023 by Tras & Co and Infobrand.Id, a renowned business recognition institution. This award recognizes the exceptional dedication and outstanding achievements of Darya-Varia in developing the pharmaceutical industry in Indonesia. Tras & Co acknowledges Darya-Varia's commitment to providing high-quality healthcare solutions and innovations for the health and well-being of the Indonesian population.

The judging process took place from April to June 2023, with the assessment criteria including: the company being a listed issuer that is not in the delisting zone; the company having achieved revenue or business income above Rp 500 billion throughout 2022 based on financial reports, and the company having obtained profits above Rp 100 billion throughout 2022 based on financial reports.

Dr.. Ian Martin Wibawa Kloer, the President Director of Darya-Varia, expressed gratitude for this award. "This award is an extraordinary achievement for us. It is the result of the hard work and dedication of our team in achieving the company's goals. We believe that this award will enhance the trust of consumers, business partners, and all our stakeholders in supporting the company's vision and mission to drive sustainable progress."

Established in 1976, Darya-Varia has a long history in the Indonesian pharmaceutical industry, and this award further strengthens its position as a provider of high-quality healthcare products, contributing to a healthier Indonesia.